Zobrazeno 1 - 10
of 13
pro vyhledávání: '"James Kimpton"'
Autor:
Benjamin Allin, Nicholas Aveyard, Timothy Campion-Smith, Eleanor Floyd, James Kimpton, Kate Swarbrick, Emma Williams, Marian Knight
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150864 (2016)
ObjectiveIdentify every paediatric surgical article published in 1998 and every paediatric surgical article published in 2013, and determine which study designs were used and whether they were appropriate for robustly assessing interventions in surgi
Externí odkaz:
https://doaj.org/article/00064cd202db4589b967028b60dd29d5
Publikováno v:
Rheumatology. 62
Background/Aims The role of highly differentiated T effector memory re-expressing CD45RA (Temra) in rheumatoid arthritis (RA) is unclear, including whether they can be used as a marker of persistent disease activity. Our aim was to investigate whethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::795e0001cb9056646df005e2e4b1e6fd
https://doi.org/10.1093/rheumatology/kead104.183
https://doi.org/10.1093/rheumatology/kead104.183
Publikováno v:
Rheumatology. 61
Background/Aims There is increasing evidence from large observational cohort studies that rituximab may result in more severe COVID-19 disease and increase the risk of death. There is also concern that rituximab impairs response to the COVID-19 vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c2e7dd6fae5a13443e50f3aeef0e194
https://doi.org/10.1093/rheumatology/keac132.005
https://doi.org/10.1093/rheumatology/keac132.005
Publikováno v:
Rheumatology. 61
Background/Aims Few long-term drug survival analyses have been reported for patients with rheumatoid arthritis (RA) treated with abatacept. Here we report a machine learning approach to investigate drug-survival of abatacept over 5 years in RA patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39ac742f86f3e28e147c86d5b915e258
https://doi.org/10.1093/rheumatology/keac133.281
https://doi.org/10.1093/rheumatology/keac133.281
Autor:
Tess Harris, Christopher J.D. Threapleton, Alexandra Robinson, Derek G Cook, James Kimpton, Iain M Carey, Stephen DeWilde, Emma H. Baker
Publikováno v:
Br J Clin Pharmacol
Aims To investigate the longitudinal exposure of English primary care patients to pharmacogenomic drugs to inform design of pre-emptive testing. Methods Sixty-three drugs were identified with dosing guidelines based on variants of 19 pharmacogenes in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6161a2b61bce2e54e785808dcc089f45
https://doi.org/10.1111/bcp.14100
https://doi.org/10.1111/bcp.14100
Autor:
James Kimpton, Teck K Khong
Publikováno v:
Drug and therapeutics bulletin. 59(10)
Commentary on:Maron DJ, Hochman JS, Reynolds HR,et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease.N Engl J Med. 2020;382:1395–1407.Series co-ordinator:Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be842b0d455a8b31e8db052ff5c652bf
https://pubmed.ncbi.nlm.nih.gov/34588183
https://pubmed.ncbi.nlm.nih.gov/34588183
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims Patient and public involvement (PPI) initiatives are important to ensure patient-centered research. However, traditional focus groups can present challenges including the recruitment and retention of patient partners. Additional chall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944fb8d9bd03dfc4b33143b5646aa499
http://europepmc.org/articles/PMC8135428
http://europepmc.org/articles/PMC8135428
Publikováno v:
Rheumatology. 60
Background/Aims Over three million people in the UK have osteoporosis; and are at a substantially increased risk of fragility fractures. There are approximately 536,000 new fragility fractures each year in the UK, with substantial associated morbidit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43d737cb42e15b9321d00e629fc19378
https://doi.org/10.1093/rheumatology/keab247.013
https://doi.org/10.1093/rheumatology/keab247.013
Autor:
Tess Harris, Derek G Cook, Stephen DeWilde, James Kimpton, Iain M Carey, Emma H. Baker, Christopher J.D. Threapleton
Publikováno v:
Br J Clin Pharmacol
Aims Polypharmacy is widespread and associated with medication-related harms, including adverse drug reactions, medication errors and poor treatment adherence. General practitioners and pharmacists cite limited time and training to perform effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065be302bd7114aef8e937b364d573fd
https://openaccess.sgul.ac.uk/id/eprint/111692/1/Threapleton_et_al-2020-British_Journal_of_Clinical_Pharmacology.pdf
https://openaccess.sgul.ac.uk/id/eprint/111692/1/Threapleton_et_al-2020-British_Journal_of_Clinical_Pharmacology.pdf
Autor:
James Kimpton, Teck K Khong
Publikováno v:
Drug and Therapeutics Bulletin. 58:135-136
Commentary by: Dr James Kimpton and Dr Teck Khong Clinical Pharmacology, St George's, University of London, UKSeries Editor: Dr Teck Khong, DTB Associate Editor Clinical Pharmacology, St George's, University of London, UKCommentary on: Kraus WE, Bhap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d85935f80b905296fad6c9e227da36e5
https://doi.org/10.1136/dtb.2020.000042
https://doi.org/10.1136/dtb.2020.000042